iShares S&P Small-Cap 600 Value
Latest iShares S&P Small-Cap 600 Value News and Updates
This Could Be a Solid Growth Driver for Myriad Genetics in 2018
Myriad Genetics (MYGN) announced the U.S. Food and Drug Administration’s (or FDA) acceptance of its supplementary premarket approval application for BRACAnalysis CDx, a DNA sequencing companion diagnostic test.
How Has Supervalu’s Stock Performed?
After falling around 30% in 2016, Supervalu’s (SVU) stock continues to be in the red in 2017.